Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1035151
PUBLISHER: QYResearch | PRODUCT CODE: 1035151
Global mRNA Vaccines & Therapeutics Sales Market Report 2021
PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Contact us about how to customize the report with add-on data.
Market Analysis and Insights:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt and will significantly affect the mRNA Vaccines & Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
Scope and Market Size:
The global mRNA Vaccines & Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global mRNA Vaccines & Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2021-2032.
By Company
- Moderna Therapeutics
- CureVac
- Translate Bio
- BioNTech
- Sangamo Therapeutics
- Argos Therapeutics
- In-Cell-Art
- eTheRNA
- Ethris
- Tiba Biotechnology
Segment by Type
- Infectious Disease Vaccines
- Cancer Vaccines
Segment by Application
- Infectious Disease
- Cancer
By Region
- North America
- Europe
- China
- Japan
- Korea
- India
TABLE OF CONTENTS
1 MRNA VACCINES & THERAPEUTICS MARKET OVERVIEW
- 1.1 mRNA Vaccines & Therapeutics Product Scope
- 1.2 mRNA Vaccines & Therapeutics Segment by Type
- 1.2.1 Global mRNA Vaccines & Therapeutics Sales by Type (2021 & 2032)
- 1.2.2 Infectious Disease Vaccines
- 1.2.3 Cancer Vaccines
- 1.3 mRNA Vaccines & Therapeutics Segment by Application
- 1.3.1 Global mRNA Vaccines & Therapeutics Sales Comparison by Application (2021-2032)
- 1.3.2 Infectious Disease
- 1.3.3 Cancer
- 1.4 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts (2021-2032)
- 1.4.1 Global mRNA Vaccines & Therapeutics Revenue Growth Rate (2021-2032)
- 1.4.2 Global mRNA Vaccines & Therapeutics Sales Growth Rate (2021-2032)
- 1.4.3 Global mRNA Vaccines & Therapeutics Price Trends (2021-2032)
- 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
- 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.5.2 Covid-19 Impact: Commodity Prices Indices
- 1.5.3 Covid-19 Impact: Global Major Government Policy
2 MRNA VACCINES & THERAPEUTICS ESTIMATES AND FORECASTS BY REGION
- 2.1 Global mRNA Vaccines & Therapeutics Market Size by Region: 2021 VS 2027 VS 2032
- 2.2 Global mRNA Vaccines & Therapeutics Retrospective Market Scenario by Region (2021-2026)
- 2.2.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)
- 2.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2021-2026)
- 2.3 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Region (2027-2032)
- 2.3.1 Global mRNA Vaccines & Therapeutics Sales Estimates and Forecasts by Region (2027-2032)
- 2.3.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2027-2032)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
- 2.4.2 Europe mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
- 2.4.3 China mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
- 2.4.4 Japan mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
- 2.4.5 Korea mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
- 2.4.6 India mRNA Vaccines & Therapeutics Estimates and Projections (2021-2032)
3 MRNA VACCINES & THERAPEUTICS COMPETITION LANDSCAPE BY PLAYERS
- 3.1 Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time
- 3.2 Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area
- 3.3 Main Pipeline Product Analysis
- 3.3.1 IVAC-Mutanome
- 3.3.2 FixVax
- 3.3.3 CV8102
- 3.3.4 CV7201
- 3.3.5 AGS-004
- 3.3.6 MRT5005 & MRT5201
- 3.3.7 SB-FIX & SB-318 & SB-913
- 3.3.8 Moderna Therapeutics Pipeline
- 3.4 Manufacturers Mergers & Acquisitions, Expansion Plans
- 3.5 Companies with mRNA Programs
- 3.5.1 Alexion Pharmaceuticals
- 3.5.2 Vertex Pharmaceuticals
- 3.5.3 Ultragenyx Pharmaceutical
- 3.6 Companies focus on mRNA Delivery
- 3.6.1 Acuitas Therapeutics
- 3.6.2 Silence Therapeutics
- 3.6.3 Arcturus Therapeutics
- 3.7 Major Pharmaceutical Companies with mRNA Programs
- 3.7.1 Boehringer Ingelheim
- 3.7.2 Novartis
- 3.7.3 Merck
- 3.7.4 AstraZeneca
- 3.7.5 Roche
- 3.7.6 Sanofi
- 3.7.7 Takeda
- 3.7.8 Johnson & Johnson
- 3.7.9 Bayer
- 3.7.10 ZIOPHARM Oncology
- 3.7.11 MaxCyte
- 3.7.12 Casebia Therapeutics
- 3.7.13 Intellia Therapeutics
4 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY TYPE
- 4.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Type (2021-2026)
- 4.1.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- 4.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2021-2026)
- 4.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2021-2026)
- 4.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Type (2027-2032)
- 4.2.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2027-2032)
- 4.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2027-2032)
- 4.2.3 Global mRNA Vaccines & Therapeutics Price Forecast by Type (2027-2032)
5 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY APPLICATION
- 5.1 Global mRNA Vaccines & Therapeutics Historic Market Review by Application (2021-2026)
- 5.2 Global mRNA Vaccines & Therapeutics Market Estimates and Forecasts by Application (2027-2032)
6 NORTH AMERICA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 6.1 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 6.2 North America mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
7 EUROPE MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 7.1 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 7.2 Europe mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
8 CHINA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 8.1 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 8.2 China mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
9 JAPAN MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 9.1 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 9.2 Japan mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
10 KOREA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 10.1 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 10.2 Korea mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
11 INDIA MRNA VACCINES & THERAPEUTICS MARKET FACTS & FIGURES
- 11.1 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Type (2021-2032)
- 11.2 India mRNA Vaccines & Therapeutics Sales Market Share Breakdown by Application (2021-2032)
12 ANALYSIS OF MRNA VACCINES & THERAPEUTICS INDUSTRY KEY MANUFACTURERS
- 12.1 Moderna Therapeutics
- 12.1.1 Company Profile
- 12.1.2 Product Information
- 12.2 CureVac
- 12.2.1 Company Profile
- 12.2.2 Product Information
- 12.3 Translate Bio
- 12.3.1 Company Profile
- 12.3.2 Product Information
- 12.4 BioNTech
- 12.4.1 Company Profile
- 12.4.2 Product Information
- 12.5 Sangamo Therapeutics
- 12.5.1 Company Profile
- 12.5.2 Product Information
- 12.6 Argos Therapeutics
- 12.6.1 Company Profile
- 12.6.2 Product Information
- 12.7 In-Cell-Art
- 12.7.1 Company Profile
- 12.7.2 Product Information
- 12.8 ETheRNA
- 12.8.1 Company Profile
- 12.8.2 Product Information
- 12.9 Ethris
- 12.9.1 Company Profile
- 12.9.2 Product Information
- 12.10 Tiba Biotechnology
- 12.10.1 Company Profile
- 12.10.2 Product Information
13 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS
- 13.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
- 13.1.1 Key Raw Materials Price Trend
- 13.1.2 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Comparison of Production Processes for Traditional, mRNA and DNA Vaccines
- 13.4 mRNA Vaccines & Therapeutics Industrial Chain Analysis
14 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
- 14.1 Marketing Channel
- 14.2 mRNA Vaccines & Therapeutics Distributors List
- 14.3 mRNA Vaccines & Therapeutics Customers
15 MARKET DYNAMICS
- 15.1 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Trends
- 15.2 Covid-19 Impact: mRNA Vaccines & Therapeutics Opportunities and Drivers
- 15.3 Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges
- 15.4 Porter's Five Forces Analysis
16 RESEARCH FINDINGS AND CONCLUSION
17 APPENDIX
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author Details
- 17.3 Disclaimer
List of Tables and Figures
- Table 1. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Type (2021 & 2032)
- Table 2. Scope of Clinical mRNA Applications
- Table 3. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate by Application (2021 & 2032)
- Table 4. Overview of the World Economic Outlook Projections
- Table 5. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
- Table 6. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
- Table 7. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
- Table 8. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
- Table 9. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
- Table 10. Covid-19 Impact: Global Major Government Policy
- Table 11. Global Market mRNA Vaccines & Therapeutics Market Size (US$ Million) by Region:2021 VS 2027 &2032
- Table 12. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Region (2021-2026)
- Table 13. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2021-2026)
- Table 14. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Region (2021-2026)
- Table 15. Global mRNA Vaccines & Therapeutics Revenue Share by Region (2021-2026)
- Table 16. Global mRNA Vaccines & Therapeutics Sales (M Doses) Forecast by Region (2027-2032)
- Table 17. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Region (2027-2032)
- Table 18. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Forecast by Region (2027-2032)
- Table 19. Global mRNA Vaccines & Therapeutics Revenue Share Forecast by Region (2027-2032)
- Table 20. Manufacturers mRNA Vaccines & Therapeutics Headquarter, Founded Time
- Table 21. Manufacturers mRNA Vaccines & Therapeutics Product Type, Research Stage, Treatment Area
- Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
- Table 23. Alexion Pharmaceuticals Company Profile
- Table 24. Vertex Pharmaceuticals Company Profile
- Table 25. Ultragenyx Pharmaceutical Company Profile
- Table 26. Acuitas Therapeutics Company Profile
- Table 27. Silence Therapeutics Company Profile
- Table 28. Product Information
- Table 29. Arcturus Therapeutics Company Profile
- Table 30. Product Information
- Table 31. Boehringer Ingelheim Company Profile
- Table 32. Novartis Company Profile
- Table 33. Merck Company Profile
- Table 34. AstraZeneca Company Profile
- Table 35. Roche Company Profile
- Table 36. Sanofi Company Profile
- Table 37. Takeda Company Profile
- Table 38. Johnson & Johnson Company Profile
- Table 39. Bayer Company Profile
- Table 40. ZIOPHARM Oncology Company Profile
- Table 41. MaxCyte Company Profile
- Table 42. Casebia Therapeutics Company Profile
- Table 43. Intellia Therapeutics Company Profile
- Table 44. Product Information
- Table 45. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2021-2026)
- Table 46. Global mRNA Vaccines & Therapeutics Sales Share by Type (2021-2026)
- Table 47. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2021-2026)
- Table 48. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2021-2026)
- Table 49. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2021-2026)
- Table 50. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Type (2027-2032)
- Table 51. Global mRNA Vaccines & Therapeutics Sales Share by Type (2027-2032)
- Table 52. Global mRNA Vaccines & Therapeutics Revenue (US$ Million) Market Share by Type (2027-2032)
- Table 53. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2027-2032)
- Table 54. Global mRNA Vaccines & Therapeutics Price (USD/Doses) by Type (2027-2032)
- Table 55. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2021-2026)
- Table 56. Global mRNA Vaccines & Therapeutics Sales Share by Application (2021-2026)
- Table 57. Global mRNA Vaccines & Therapeutics Sales (M Doses) by Application (2027-2032)
- Table 58. Global mRNA Vaccines & Therapeutics Sales Share by Application (2027-2032)
- Table 59. North America mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 60. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 61. North America mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 62. North America mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 63. North America mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 64. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 65. North America mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 66. North America mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 67. Europe mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 68. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 69. Europe mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 70. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 71. Europe mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 72. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 73. Europe mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 74. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 75. China mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 76. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 77. China mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 78. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 79. China mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 80. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 81. China mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 82. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 83. Japan mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 84. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 85. Japan mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 86. Japan mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 87. Japan mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 88. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 89. Japan mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 90. Japan mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 91. Korea mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 92. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 93. Korea mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 94. Korea mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 95. Korea mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 96. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 97. Korea mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 98. Korea mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 99. India mRNA Vaccines & Therapeutics Sales by Type (2021-2026) & (M Doses)
- Table 100. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2021-2026)
- Table 101. India mRNA Vaccines & Therapeutics Sales by Type (2027-2032) & (M Doses)
- Table 102. India mRNA Vaccines & Therapeutics Sales Market Share by Type (2027-2032)
- Table 103. India mRNA Vaccines & Therapeutics Sales by Application (2021-2026) & (M Doses)
- Table 104. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2021-2026)
- Table 105. India mRNA Vaccines & Therapeutics Sales by Application (2027-2032) & (M Doses)
- Table 106. India mRNA Vaccines & Therapeutics Sales Market Share by Application (2027-2032)
- Table 107. Moderna Therapeutics Company Profile
- Table 108. CureVac Company Profile
- Table 109. Translate Bio Company Profile
- Table 110. BioNTech Company Profile
- Table 111. Sangamo Therapeutics Company Profile
- Table 112. Argos Therapeutics Company Profile
- Table 113. In-Cell-Art Company Profile
- Table 114. ETheRNA Company Profile
- Table 115. Ethris Company Profile
- Table 116. Tiba Biotechnology Company Profile
- Table 117. Out-of-pocket Preclinical and Clinical Period Cost Per Investigational Biopharmaceutical Compound
- Table 118. Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound
- Table 119. mRNA Vaccines & Therapeutics Customers List
- Table 120. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Key Trends
- Table 121. Covid-19 Impact: mRNA Vaccines & Therapeutics Key Opportunities and Drivers
- Table 122. Covid-19 Impact: mRNA Vaccines & Therapeutics Market Challenges
- Table 123. Research Programs/Design for This Report
- Table 124. Key Data Information from Secondary Sources
- Table 125. Key Data Information from Primary Sources
List of Figures
- Figure 1. mRNA Vaccines & Therapeutics Product Picture
- Figure 2. Global mRNA Vaccines & Therapeutics Market Share by Type in 2027
- Figure 3. Global mRNA Vaccines & Therapeutics Market Share by Type in 2032
- Figure 4. Global mRNA Vaccines & Therapeutics Market Share by Application in 2027
- Figure 5. Global mRNA Vaccines & Therapeutics Market Share by Application in 2032
- Figure 6. Infectious Disease Examples
- Figure 7. Cancer Examples
- Figure 8. Global mRNA Vaccines & Therapeutics Revenue, (US$ Million), 2021 VS 2027 VS 2032
- Figure 9. Global mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 10. Global mRNA Vaccines & Therapeutics Price Trends Growth Rate (2021-2032) & (USD/Doses)
- Figure 11. Commodity Prices-Metals Price Indices
- Figure 12. Commodity Prices- Precious Metal Price Indices
- Figure 13. Commodity Prices- Agricultural Raw Material Price Indices
- Figure 14. Commodity Prices- Food and Beverage Price Indices
- Figure 15. Commodity Prices- Fertilizer Price Indices
- Figure 16. Commodity Prices- Energy Price Indices
- Figure 17. G20+: Economic Policy Responses to COVID-19
- Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2026
- Figure 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2027
- Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region: 2032
- Figure 21. North America mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 22. North America mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 23. Europe mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 24. Europe mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 25. China mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 26. China mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 27. Japan mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 28. Japan mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 29. Korea mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 30. Korea mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 31. India mRNA Vaccines & Therapeutics Revenue (US$ Million) Growth Rate (2021-2032)
- Figure 32. India mRNA Vaccines & Therapeutics Sales (M Doses) Growth Rate (2021-2032)
- Figure 33. IVAC-Mutanome Pipeline
- Figure 34. FixVax Pipeline
- Figure 35. CV8102 Pipeline
- Figure 36. CV7201 Pipeline
- Figure 37. CV7201 Pipeline
- Figure 38. MRT5005 & MRT5201 Pipeline
- Figure 39. SB-FIX Pipeline
- Figure 40. SB-318 & SB-913 Pipeline
- Figure 41. Moderna Therapeutics Pipeline
- Figure 42. mRNA Vaccines & Therapeutics Product Information of Acuitas Therapeutics
- Figure 43. mRNA Vaccines & Therapeutics Product Information of ZIOPHARM Oncology
- Figure 44. mRNA Vaccines & Therapeutics Product Information of Casebia Therapeutics
- Figure 45. mRNA Vaccines & Therapeutics Product Picture of Moderna Therapeutics
- Figure 46. mRNA Vaccines & Therapeutics Product Picture of CureVac
- Figure 47. mRNA Vaccines & Therapeutics Product Picture of Translate Bio
- Figure 48. mRNA Vaccines & Therapeutics Product Picture of BioNTech
- Figure 49. mRNA Vaccines & Therapeutics Product Picture of Sangamo Therapeutics
- Figure 50. mRNA Vaccines & Therapeutics Product Picture of Argos Therapeutics
- Figure 51. mRNA Vaccines & Therapeutics Product Picture of In-Cell-Art
- Figure 52. mRNA Vaccines & Therapeutics Product Picture of ETheRNA
- Figure 53. mRNA Vaccines & Therapeutics Product Picture of Ethris
- Figure 54. mRNA Vaccines & Therapeutics Product Picture of Tiba Biotechnology
- Figure 55. Typical Phases from Research to the Market for a mRNA Vaccines Candidate
- Figure 56. Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
- Figure 57. Comparison of Production Processes for Traditional, mRNA and DNA Vaccines
- Figure 58. Differences between Traditional, mRNA and DNA Vaccines
- Figure 59. History of Vaccine Development
- Figure 60. Differences between Traditional, MRNA and DNA Vaccines (Delivery)
- Figure 61. mRNA Vaccines & Therapeutics Industrial Chain Analysis
- Figure 62. Channels of Distribution
- Figure 63. Distributors Profiles
- Figure 64. Porter's Five Forces Analysis
- Figure 65. Bottom-up and Top-down Approaches for This Report
- Figure 66. Data Triangulation
- Figure 67. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.